Mozafari, P.; Ibrahim, S. A.; Pawar, A. A.; Ali, Z. I. O.; Nair, A. S. Balancing Long-Term Efficacy and Immunological Safety: Serious Infection Risk During Extended Ocrelizumab Therapy in Multiple Sclerosis. JR 2026, 4, 57-69.